<DOC>
	<DOCNO>NCT00504062</DOCNO>
	<brief_summary>To investigate effect safety budesonide Turbuhaler® 100 μg/dose 200 μg/dose twice daily 6 week Japanese child bronchial asthma age 5 year 15 year old need inhale glucocorticosteroid treatment . To compare efficacy budesonide Turbuhaler® 100 μg/dose 200 μg/dose twice daily 6 week fluticasone Diskus® 50 μg/dose 100 μg/dose twice daily 6 week .</brief_summary>
	<brief_title>Open-label , Safety Efficacy Study Pulmicort® Turbuhaler® Japanese Children With Bronchial Asthma</brief_title>
	<detailed_description />
	<mesh_term>Asthma</mesh_term>
	<mesh_term>Budesonide</mesh_term>
	<mesh_term>Fluticasone</mesh_term>
	<criteria>Provision sign write informed consent patient 's legal representative ; possible sign write informed consent obtain patient Patients diagnose bronchial asthma regardless type asthma i.e . perennial seasonal , atopic nonatopic Males/females 515 yr old able experience inhale turbuhaler diskus . investigator check whether patient inhale appropriately use training devise `` Turbuhaler trainer '' Patients bronchial asthma require treatment inhaled steroid ( patient drug therapy , asthma poorly control ) Patients already treat inhaled GCS least 3 month prehistory asthma obtain write informed consent Use regular ( 3 day ) systemic ( oral , intravenous intramuscular ) steroid within 30 day observation period The daily dose inhale GCS within 30 day observation period patient already treat inhaled GCS beyond fluticasone propionate ( FP ) 200 µg/day beclomethasone dipropionate ( BDP ) 200 μg/day . Respiratory infection , opinion investigator ( ) , may affect efficacy evaluation e.g . low airways infection pneumonia , infection available effective antimicrobial drug deep seat mycosis within 30 day observation period . Concurrent serious disease liver , kidney , heart complication , opinion investigator ( ) , may either put patient risk participation study , may influence result study , patient 's ability participate study Contraindications ( e.g. , know suspected allergy ) budesonide , fluticasone lactose contain investigational product Participation another clinical study within 12 week prior observation period study Previous enrolment present study Current use budesonide turbuhaler Pregnancy possible pregnancy , plan pregnant study period Patients whose legal representative/caregiver involve plan conduct study ( applies AstraZeneca staff staff study site ) Other subject consider inappropriate participate study judge investigator</criteria>
	<gender>All</gender>
	<minimum_age>5 Years</minimum_age>
	<maximum_age>15 Years</maximum_age>
	<verification_date>August 2011</verification_date>
	<keyword>asthma</keyword>
	<keyword>bronchial</keyword>
</DOC>